Business
Verify Smart Corporation Signs Letter of Intent to Acquire Equity Stake and Exclusive International Reseller Rights in Med-Con Technologies, LLC
Verify Smart Corporation Signs Letter of Intent to Acquire Equity Stake and Exclusive International Reseller Rights in Med-Con Technologies, LLC.
About this update from Verify Smart Corp.
[{"type":"text","content":"\n \n Verify Smart Corporation (VSMR) a Global innovator in financial fraud \n prevention and digital distribution solutions announced today that it \n has signed a Letter of Intent to acquire an equity stake and exclusive \n international reseller rights in Med-Con Technologies, LLC for cash and \n stock.\n \n \n Med-Con Technologies provides a patented solution (MedSkedTM \n ) for improved medication adherence. MedSkedTM gives patients \n the ability to more effectively self-manage and keep track of their \n daily medication dosing. Med-Con’s solutions are effectively assisting \n patients in over thirty two countries, and twenty four languages.\n \n \n Med-Con has also developed MedCon Mobile Smart LabelTM which \n is a mobile based patient adherence solution for the Pharmaceutical \n industry and is currently being tested by a major Pharmaceutical company \n with other pilots scheduled. The cloud based SaaS software manages the \n patient’s medication dosing schedule via a mobile device while sending \n vital adherence data to the Pharmaceutical clinical trial teams for \n analysis via the MedCon CentralTM data portal. Verify Smart \n and Med-Con believe this product is groundbreaking and a huge first to \n market play in the Pharmaceutical space.\n \n \n Pharmaceutical Manufacturing Magazine said “Medication Adherence is \n arguably the largest problem in healthcare, it is estimated that \n medication non-adherence causes 30 – 50% of treatment failures and \n 125,000 deaths annually. The direct cost to healthcare is estimated as \n high as $289 billion annually. Pharmaceutical companies are motivated to \n increase adherence because higher compliance equates to better treatment \n effectiveness and overall better patient health...and of course, higher \n drug sales.”\n \n \n Tony Cinotti, President of Verify Smart said “Verify Smart will work \n closely with Med-Con Technologies to establish Verify Smart as the \n exclusive international reseller of MedSked and MedCon Mobile Smart \n Label for Pharmaceutical Companies, Pharmacy chains and Specialty \n Pharmacy markets. Verify Smart will also, in parallel, build an \n additional adherence solution specifically for Retail Pharmacies. This \n will greatly increase Med-Con sales worldwide. Pharmacy customers taking \n prescription medications...